AGC Biologics has announced the appointment of Christopher Holt as Site Head/General Manager of its Bothell, Washington operations. Holt will provide leadership and site management to ensure AGC Biologics' continued delivery of world-class contract development and manufacturing services.
Holt brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, having worked for Lonza, DSM/Patheon and GlaxoSmithKline in the US and Europe.
"We are pleased that Chris Holt is bringing his deep knowledge and expertise to AGC Biologics," said Patricio Massera, AGC Biologics Chief Executive Officer. "The role of Site Head/General Manager in our global headquarters, located in our Bothell, Washington facility is essential to our operation's expansion and growth. Chris' expertise, experience in our industry and strong leadership skills are an excellent asset to lead the growth of our Bothell site and achievement of our goals and objectives."